As recently as five years ago, there was no reasonably effective treatment for patients with advanced melanoma that had metastasized. Recent innovations in immunotherapies, therapies that stimulate one’s immune system to destroy the cancer cells, have changed the way we treat cancer. Melanoma, more than any other cancer, has been affected by the development of these new immunotherapies. This is an exciting time to be a researcher and clinician who treats melanoma.
Treatment options for patients with advanced melanoma continue to expand:
Combination Therapy: Two Are Better Than One
Trials have demonstrated that the combination of ipilimumab and nivolumab can achieve significant tumor shrinkage in about 60 percent of patients. This is a much higher rate than we’ve achieved with either ipilimumab or nivolumab alone. In majority of patients whose tumor responded, their melanomas did not get worse during and even after the treatment.
We need more research to determine whether this combination will eventually improve survival rates compared to either ipilimumab or nivolumab. At Inova, we have a clinical trial of ipilimumab and nivolumab in patients with melanoma that has spread to the brain to find out whether this combination works in the brain as well.
New Treatment Protocol?
Is this combination going to be an option for everyone with advanced melanoma? I think the recommendation has to be made individually, based on a patient’s overall health and other conditions he or she may have. This therapy combination can cause serious side effects, including inflammation in the bowel, lung, liver and kidneys. The good news is that most of side effects are reversible with steroid treatment. As always, communication with the treatment team will be crucial in detecting and treating the side effects.
According to the U.S. Centers for Disease Control and Prevention, nearly 50% of adults in…
Heather Perez Saiz, MA, LCSW, CCTSW, is the Independent Living Donor Advocate at Inova Fairfax…
Palak Shah, MD, MS Fairfax, VA — A research team at Inova Schar Heart and…
Jason Bonomo, MD, PhD, is a cardiologist at Inova Schar Heart and Vascular. Dr. Bonomo…
Update as of April 24, 2024: Inova’s structural heart team has now completed the first…
The Peterson Family Fairfax, VA, April 16, 2024 – Inova today announced a transformational gift…